MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
AVLN — Avalyn Pharma Inc. Common Stock
NasdaqAvalyn Pharma Inc. Common Stock
$28.13
+0.71(+2.59%)
- O
- 28.59
- H
- 28.92
- L
- 27.72
- V
- 526.19K
⏱️ End-of-day dataAs of Oct 2, 2026
AVLN — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 |
|---|---|
| Fiscal Date | 2026-03-31 |
| Period | quarterly |
| Year | 2,026.00 |
| Cash And Cash Equivalents | $92.31M |
| Other Short Term Investments | $30.82M |
| Prepaid Assets | $3.88M |
| Total Current Assets | $13.00M |
| Properties | $1.43M |
| Machinery Furniture Equipment | 415,000.00 |
| Construction In Progress | 12,000.00 |
| Leases | 936,000.00 |
| Accumulated Depreciation | -117,000.00 |
| Other Non Current Assets | $3.00M |
| Total Non Current Assets | $5.68M |
| Total Assets | $13.57M |
| Accounts Payable | $3.15M |
| Accrued Expenses | $6.29M |
| Short Term Debt | 507,000.00 |
| Pensions | $1.84M |
| Total Current Liabilities | $11.79M |
| Long Term Debt | $15.90M |
| Total Non Current Liabilities | $38.81M |
| Total Liabilities | $39.99M |
| Common Stock | 24,000.00 |
| Retained Earnings | $-29.22M |
| Other Shareholders Equity | 12,000.00 |
| Total Shareholders Equity | $-26.42M |
| Additional Paid In Capital | $27.95M |